Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - Sunshine Biopharma, Inc | mtnwstbus10k73109x21_102909.htm |
| EX-32.1 - EXHIBIT 32.1 - Sunshine Biopharma, Inc | mtnwstbus10k73109x32_102909.htm |
| EX-31.2 - EXHIBIT 31.1 - Sunshine Biopharma, Inc | mtnwstbus10k73109x312_102909.htm |
| 10-K - ANNUAL REPORT FOR YEAR ENDED JULY 31, 2009 - Sunshine Biopharma, Inc | mtnwstbus10k73109_102909.htm |
Exhibit
31.1
Certification
Pursuant to Section 302
of the
Sarbanes-Oxley Act of 2002
I,
Matthew Milonas certify that:
1. I
have reviewed this annual report of Mountain West Business Solutions, Inc. on
Form 10-K;
2. Based
on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading
with respect to the period covered by this;
3. Based
on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the small business issuer as
of, and for, the periods presented in this report;
4. The
small business issuer's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-a5(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(e) and
15d-a5(e)) for the small business issuer and have;
|
(a)
|
Designed
such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure
the material information relating to the small business issuer, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;
|
|
(b)
|
Designed
such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting
principles;
|
|
(c)
|
Evaluated
the effectiveness of the small business issuer's disclosure controls and
procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such
evaluation.
|
|
(d)
|
Disclosed
in this report any change in the small business issuer's internal control
over financial reporting that occurred during the small business issuer's
most recent fiscal quarter (the small business issuer's fourth fiscal
quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the small business issuer's
internal control over financial reporting;
and
|
5. The
small business issuer other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
small business issuer's auditors and the audit committee of the small business
issuer's board of directors (or person performing the equivalent
functions);
|
(a)
|
All
significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the small business issuer's ability
to record, process summarize and report financial information;
and
|
|
(b)
|
Any
fraud, whether or not material, that involves management or other
employees who have a significant role in the small business issuer's
internal controls over financial
reporting.
|
Date: October
29, 2009
|
By:
|
/s/ Matthew
Milonas
|
||
|
Matthew
Milonas
Chief
Executive Officer
|
|||